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A subset of nuclear-encoded RNAs has to be imported into mitochondria for the proper replication and transcription of the mitochon-
drial genome and, hence, for proper mitochondrial function. Polynucleotide phosphorylase (PNPase or PNPT1) is one of the very few
components known to be involved in this poorly characterized process in mammals. At the organismal level, however, the effect of
PNPase dysfunction and impaired mitochondrial RNA import are unknown. By positional cloning, we identified a homozygous
PNPT1 missense mutation (c.1424A>G predicting the protein substitution p.Glu475Gly) of a highly conserved PNPase residue within
the second RNase-PH domain in a family affected by autosomal-recessive nonsyndromic hearing impairment. In vitro analyses in
bacteria, yeast, and mammalian cells showed that the identified mutation results in a hypofunctional protein leading to disturbed
PNPase trimerization and impaired mitochondrial RNA import. Immunohistochemistry revealed strong PNPase staining in the murine
cochlea, including the sensory hair cells and the auditory ganglion neurons. In summary, we show that a component of the mitochon-
drial RNA-import machinery is specifically required for auditory function.The integrity and function of mammalian mitochondria is
critically dependent on the import of selected macromole-
cules that are encoded by the nuclear genome. The import
of nuclear-encoded proteins into mitochondria is a well-
studied phenomenon, and most of the proteins involved
in this complex process of protein translocation and
processing have been identified.1 Consistent with the
importance of this process for mitochondrial function
and the high energy demand of specific tissues, it has
been shown that germline mutations in genes encoding
members of this import machinery, as well as those encod-
ing transported substrates, can cause a variety of human
diseases characterized by the occurrence of diverse neuro-
logic, cardiologic, and metabolic symptoms.2 In sharp
contrast, little is known about the import of nuclear-
encoded RNAs into mitochondria; such import has been
shown to be required for proper replication and transcrip-
tion of the mitochondrial genome.3,4 The known trans-
ported RNAs are small RNAs including 5S rRNA, RNase
P RNA, MRP RNA, and different tRNAs.5 The only estab-
lished protein components of this import machinery in1Institute of Human Genetics, University of Ulm, 89081 Ulm, Germany; 2Insti
3Department of Chemistry and Biochemistry, University of California, Los Ang
du Maroc, 20100 Casablanca, Morocco; 5InnerEarLab, Department of Otolaryn
6Department of Pathology and Laboratory Medicine, David Geffen School of
USA; 7Center for Molecular Medicine Cologne, University of Cologne, 5067
Cologne, 50674 Cologne, Germany; 9Cologne Center for Genomics, University
of Sussex, Falmer, Brighton BN1 9QG, UK; 11Cologne Excellence Cluster on Ce
50674 Cologne, Germany; 12Institute for Genetics, University of Cologne, 5
University of Go¨ttingen, 37073 Go¨ttingen, Germany; 14Molecular Biology In
15Jonsson Comprehensive Cancer Center, Broad Stem Cell Research Center,
of California, Los Angeles, Los Angeles, CA 90095, USA
*Correspondence: christian.kubisch@uni-ulm.de
http://dx.doi.org/10.1016/j.ajhg.2012.09.002. 2012 by The American Societ
The Americanmammals are rhodanese,6 MRP-L18,7 and polynucleotide
phosphorylase (PNPase or PNPT1).8 At the cellular level,
it has been demonstrated that downregulation of PNPT1
leads to mitochondrial dysfunction with an impairment
of mitochondrial RNA processing and the accumula-
tion of polycistronic transcripts.8 However, the conse-
quence of PNPase dysfunction in complex tissues or whole
organisms is unknown, and it is thus unclear whether
different tissues might have differing degrees of depen-
dence on PNPase function andmitochondrial RNA import.
We studied a consanguineous Moroccan family with
three siblings (two males and one female) affected by a
severe hearing impairment (Figure 1A), which was first
noticed in early childhood and resulted in the inability
to acquire normal speech. Three more siblings and both
parents, who are first-degree cousins, are unaffected, con-
firming an autosomal-recessive inheritance pattern in
this family. The study was approved by the ethics commit-
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Figure 1. Identification of the Disease-Causing PNPT1Mutation in a Consanguineous Family Affected by Nonsyndromic Hearing Loss
(A) Pedigree of the DFNB70-linked family. Microsatellite haplotypes indicate homozygosity between markers D2S119 and D2S378 in
affected family members (filled symbols). According to the Genome Reference Consortium release h37, February 2009, the linked region
spans approximately 13.2 Mb.
(B) Pure-tone audiograms of the three affected children with severe hearing loss; an audiogram of an unaffected sibling is shown for
comparison. The following abbreviations are used: dB(HL), decibel hearing loss; and Hz, frequency in Hertz.
(C) Genome-wide homozygosity mapping identified two putative loci (black arrows) withmultipoint LOD scores of 2.7 and 1.5 on chro-
mosomes 2 and 12, respectively (see also Figure S1).
(D) Illustration shows the position of the DFNB70 locus on the short arm of chromosome 2; PNPT1 is at the centromeric end (see also
Figure S1 and Table S1).
(E) Direct sequencing identified a homozygous c.1424A>Gmutation in PNPT1 in affected individuals (upper electropherogram) and in
a heterozygous state in unaffected carriers (middle). A homozygous wild-type (WT) sequence is shown on the bottom. Amino acid abbre-
viations are shown above the sequence traces.
(F) A PNPasemonomer consists of two RNase-PH domains, which are separated by an a-helix, and two RNA binding domains, KH and S1.
Additionally, mammalian PNPase carries an N-terminal mitochondrial targeting sequence (MTS). The multiple-sequence alignment was
generated with the ClustalW2 Multiple Sequence Alignment tool and depicts conservation of the crucial glutamic acid residue. Amino
acid position 430 in E. coli corresponds to position 475 in humans.or their parents. The affected individuals were evaluated
by detailed medical-history interviews and a physical
examination, and they underwent an otological examina-
tion and pure-tone audiometry with air and bone conduc-
tion measurements. Taken when the affected children
were between the ages of 12 (IV:6) and 17 (IV:4), pure-
tone audiograms confirmed a hearing loss of at least 80
dB for all tested frequencies (Figure 1B). Clinical examina-
tions revealed no obvious additional symptoms, such as
vestibular dysfunction, cognitive or motor disturbances,
or signs of metabolic diseases, in any of the affected indi-
viduals, leading to the classification of nonsyndromic
hearing impairment (the oldest individual was 24 years
of age at the last examination). We first excluded GJB2920 The American Journal of Human Genetics 91, 919–927, Novemb(encoding connexin 26; MIM 121011) mutations, the
most common cause of autosomal-recessive nonsyn-
dromic hearing impairment (ARNSHI), by direct sequenc-
ing of genomic DNA of affected family members.
To identify the chromosomal locus underlying the
sensory disorder in this family, we performed genome-
wide homozygosity mapping of seven family members
(the parents, three affected siblings, and two unaffected
siblings) by using the Affymetrix GeneChip Human
Mapping 10K SNP array Xba142 (version 2.0). Data
handling, evaluation, and statistical analysis were per-
formed as described before.9 We identified two putative
loci, one on chromosome 2 and a second of weaker sig-
nificance on chromosome 12, with multipoint LODer 2, 2012
scores of 2.7 (which is the maximum expected LOD score
in this family and thus means perfect cosegregation of
marker haplotypes with the phenotype) and 1.5, respec-
tively (Figure 1C). We subsequently excluded the putative
locus on chromosome 12 by genotyping microsatellite
markers on the basis of nonsegregation of marker alleles
with the phenotype (Figure S1, available online). By
contrast, the putatively linked region on chromosome 2
was confirmed by microsatellite genotyping in all eight
family members (Figure 1A). The linkage analysis defined
a locus on the short arm of chromosome 2 (2p16.1), which
is delineated by markers D2S119 and D2S378 and spans
approximately 13.2 Mb of genomic sequence (Figure 1D)
and which does not include or overlap with any known
ARNSHI locus. The locus, named DFNB70 according to
the official deafness loci nomenclature, harbors 49 anno-
tated protein-coding genes (Figure S1 and Table S1).
We analyzed the coding exons and adjacent splice sites
of all 49 positional candidate genes within the linked
chromosomal interval by PCR amplification of genomic
DNA from one affected individual and by subsequent
direct Sanger sequencing. Primer sequences, which were
obtained with Primer3, are available upon request. In the
coding sequence, we identified just a single nonannotated
nucleotide change (c.1424A>G [Figure 1E]) representing
a missense mutation in PNPT1 (RefSeq accession number
NM_033109.3), which codes for polynucleotide phos-
phorylase (PNPase or PNPT1).10–12 At the protein level,
this transition at nucleotide position 1,424 predicts an
exchange of a negatively charged glutamic acid to glycine,
p.Glu475Gly, which is located within the second RNase-
PH domain of the protein (Figure 1F). The alteration cose-
gregated with the hearing loss in the family—only affected
individuals showed homozygosity for c.1424A>G—
whereas both parents and the three unaffected siblings
were heterozygous carriers. The missense alteration was
not annotated in either dbSNP or the 1000 Genomes
Project database; moreover, it was not present in over
10,000 Exome Variant Server alleles of European or
African American descent, precluding that it represented
a benign or more common polymorphism. Furthermore,
we did not identify themissense alteration in 192 German,
160 Moroccan, or 57 Turkish control individuals as tested
by a mutation-specific Hpy188III restriction digest. The
glutamic acid is located in a functional domain of the
protein and is strictly conserved throughout evolution
(Figure 1F), compatible with an important functional role
for this residue. All together, the genetic data strongly
suggest a causative role for the PNPT1 missense alteration
in hearing impairment.
PNPT1 has been reported to have a broad tissue ex-
pression, but expression in the inner ear has not been
specifically analyzed until now. Using RT-PCR on total
RNA isolated from postnatal day (P)2 wild-type (WT)
mice (TRIzol reagent, Invitrogen, Darmstadt, Germany),
we found Pnpt1 mRNA expression in the murine cochlea
and various other tissues (Figure 2A), confirming theThe Americanbroad Pnpt1 expression pattern, including in the inner
ear. In addition, immunoblot analysis with a commercial
PNPase antibody (polyclonal rabbit anti-PNPase, Catalog
No. 14487-1-AP, Proteintech, Manchester, UK) also re-
vealed PNPase in extracts from murine total cochlea and
brain (Figure 2B). To analyze the cellular localization of
PNPase within the cochlea, we performed immunohisto-
chemistry. Cochleae from P6 mice were dissected, and
immunohistochemistry was performed according to stan-
dard procedures. The immunohistological staining pattern
demonstrated a broad PNPase distribution in the inner
ear, including the sensory hair cells (Figure 2C) and spiral
ganglion neurons (Figure 2J), and was independently
confirmed by the use of another commercial antibody
(data not shown). Immunohistochemistry in organ-of-
Corti whole-mount preparations13 from P19 mice further
confirmed PNPase localization in inner and outer hair
cells (Figure 2G). Heat-shock protein 60 (Hsp60) and
apoptosis-inducing factor (Aif) were selected as mitochon-
drial markers (Figures 2D, 2H, and 2K) and colocalized
with PNPase (Figures 2E, 2I, and 2L), thus confirming the
predominant mitochondrial localization of PNPase also
in the inner ear.
To independently assess inner-ear expression of Pnpt1,
we analyzed its expression in Danio rerio. Because the
zebrafish ortholog of PNPT1 (pnpt1) was not annotated
in public genome databases, we performed RT-PCR
(OneStep RT-PCR Kit, QIAGEN, Hilden, Germany) and
50 and 30 RACE (rapid amplification of cDNA ends) PCR
(50–30 RACE Kit 2nd generation, Roche, Mannheim,
Germany) experiments based on the sequence of expressed
sequence tags (ESTs; GenBank accession numbers
EE694402.1 and CT592833.2) representing parts of pnpt1;
these ESTs were identified by TBLASTN analysis with the
human PNPase protein sequence. The coding sequence
of pnpt1 (Figure S2) consisted of a 2,328 bp open reading
frame encoding a protein of 776 amino acids. Human
PNPase and the zebrafish ortholog show a high degree
of conservation with approximately 70% amino acid se-
quence identity (Figure S3), which includes the conserved
glutamic acid at human position 475 corresponding to
Glu469 in Danio rerio. Also, the zebrafish ortholog is pre-
dicted to have a mitochondrial targeting signal (MTS),
and transient overexpression of pnpt1 in mouse embryonic
fibroblasts (MEFs) indeed showed a mitochondrial locali-
zation of the encoded protein (data not shown). For
in situ hybridization, a zebrafish EST clone (GenBank
accession number EE702826) harboring approximately
900 bp of pnpt1 was linearized for obtaining antisense
and sense strands. In vitro transcription was carried out
with the DIG RNA Labeling Kit (Roche, Mannheim,
Germany) according to the manufacturer’s instructions.
In situ hybridization was performed as previously
described14 and revealed strong pnpt1 expression
(maternal expression) at the two-cell stage (Figure 3A)
and a rather broad staining pattern during early develop-
ment (Figures 3B–3D); this pattern became more restrictedJournal of Human Genetics 91, 919–927, November 2, 2012 921
Figure 2. Expression of Pnpt1 and Detec-
tion of PNPase in the Murine Inner Ear
(A) Total RNA from selected tissues was
isolated from P2 WT mice. RT-PCR using
a forward primer in exon 8 and a reverse
primer in exon 9 was performed. Amplifi-
cation of cDNA leads to a 179 bp product,
whereas amplification of genomic DNA
(gDNA) results in a 327 bp product as
a result of the inclusion of intron 8.
Pnpt1 expression was observed in all
tissues studied. ‘‘H2O’’ indicates the water
control.
(B) In vitro translated and purified re-
combinant PNPase (PNPase-WT-V5-His) is
recognized by PNPase antibody in immu-
noblot analysis. Endogenous murine
PNPase was detected in brain and cochlea
at P0 and P2, respectively. The higher
molecular weight of the recombinant
PNPase (þ10 kDa) is due to the additional
V5-His tag and the nonprocessing of
the MTS. Protein mass was calculated
with the PeptideMass online calculation
tool.
(C–L) Immunohistochemistry of PNPase
in the murine inner ear.
(C) Cross-section of P6 mouse cochlea
reveals PNPase staining in hair cells and
surrounding tissue.
(D and E) Heat-shock protein 60 (Hsp60)
was used as a mitochondrial marker (D)
and colocalizes with PNPase (E).
(F) Sketch illustrates PNPase levels in the
organ of Corti and surrounding cells. The
following abbreviations are used: IHC,
inner hair cell; and OHCs, outer hair cells.
(G–I) Organ-of-Corti whole-mount prepa-
ration from P19 mice. Maximum intensity
confocal projections of three Z-planes
(~1 mm depth) at the level of OHC apexes
and IHC somata are shown.
(G) PNPase staining in OHCs and IHCs.
(H) AIF (apoptosis inducing factor) anti-
body was used as a positive control for
mitochondria.
(I) PNPase and AIF merged. CtBP2 (also known as Ribeye) antibody was used for better orientation in the sample because it stained
most brightly the IHC nuclei (*) and the smaller presynaptic densities of the afferent synapses (arrows). Both AIF and PNPase displayed
a staining pattern consistent with that of mitochondria.
(J) Cross-section showing PNPase staining in spiral ganglion neurons.
(K) Hsp60 was used for staining mitochondria.
(L) PNPase and Hsp60 merged.later in development and showed pronounced expression
in the tectum, the gill arches, and the developing ear
(Figures 3E and 3F). In summary, we showed conserved
expression of Pnpt1/pnpt1 in the inner ear in mice and
in the ear in zebrafish, as well as high PNPase levels in
the murine cochlea, which is compatible with a role for
polynucleotide phosphorylase in auditory function.
A possible functional consequence of the missense alter-
ation could be a decrease in protein stability or an altered
subcellular localization. We therefore subcloned PNPT1
WT cDNA in a mammalian expression vector (pcDNA3.1/
V5-His-TOPO Invitrogen, Darmstadt, Germany) and
introduced the c.1424A>G point mutation by in vitro
mutagenesis (QuikChange II Site-Directed Mutagenesis922 The American Journal of Human Genetics 91, 919–927, NovembKit, Agilent, Waldbronn, Germany). However, by transient
overexpression in human embryonic kidney (HEK) 293T
cells, we did not observe either potential effect (Figure S4).
The unaltered mitochondrial localization of the protein
encoded by the mutant cDNA was confirmed in trans-
fected COS7 cells and transformed yeast (Figure S4).
Because of the mitochondrial function of PNPase, we
also analyzed protein stability after induction of oxidative
stress. HEK 293T cells expressing either WT or mutant
PNPT1 were incubated with various substances, but,
again, we could not demonstrate a significant difference
between the WT and mutant protein stability (Figure S4).
Glu475 is located in the second RNase-PH domain of
PNPase and is strictly conserved in orthologs from overer 2, 2012
Figure 3. In Situ Hybridization of the PNPT1 Ortholog in
Zebrafish
(A) Maternal expression of pnpt1 in 2-cell-stage fertilized zebrafish
eggs.
(B–C) At 50% and 80% epiboly, pnpt1 mRNA is broadly expressed
in the whole embryo.
(D) 24 hr postfertilization (hpf) expression is highest in the head
area and disappears toward the tail.
(E–F) 48 hpf and 120 hpf expression becomes restricted to the
tectum, the gill arches, and the developing ear (indicated by
arrows).
Figure 4. Three-Dimensional Modeling of Human PNPase
The structure of bacterial PNPase from E.coli (Protein Data Bank
accession number 3CDI) is a homotrimer; the subunits are indi-
cated by different colors (light red, green, and blue). The glutamate
residue corresponding to Glu475 of human PNPase (red space-
filling representation) forms a salt bridge to an arginine residue
(blue spacefill) of the neighboring subunit (see also Figure S5).
The pink dotted lines indicate unresolved parts of the structure.
(A) Top view along the trimer symmetry axis; all three salt bridges
are indicated.
(B) Side view; only one of the salt bridges is shown.500 published prokaryotic and eukaryotic species for
which protein sequences are available in the UCSC
multiple-species sequence-alignment database (Figure S5
and data not shown). To possibly predict a functional
consequence of the p.Glu475Gly alteration, we modeled
human PNPase to the published structure of the E. coli
ortholog15 by using the PHYRE2 server.16 The three-
dimensional modeling of PNPase revealed that Glu475 is
not located close to the central canal of the PNPase trimer,
which is involved in RNA processing and possibly trans-
port, and that p.Glu475Gly is not predicted to significantly
change the functional properties of the PNPase monomer.
After analysis of the quaternary structure of the PNPase
trimer, it appears that the glutamic acid residue p.Glu430
in E. coli (corresponding to p.Glu475 in humans) is located
at the trimerization interface (Figures 4A and 4B) and that
the negatively charged glutamic acid is predicted to build
a salt bridge with the positively charged arginine residue
at position 66 (corresponding to p.Lys105 in humans) of
the neighboring monomer (Figures 4A and 4B). More
than 95% of the over 500 published PNPase orthologs
have a positively charged residue at this position (data
not shown). Changing Glu475 to glycine, as found inThe Americanthe family with ARNSHI, is predicted to disrupt the salt
bridge and will thus most likely interfere with PNPase
function by compromising trimerization.
To study this predicted functional deficit of the altered
PNPase, we first performed a bacterial-growth assay. In
E. coli, PNPase exists as a homotrimeric complex, associates
solely with RhlB (an RNA helicase that facilitates degrada-
tion of double-stranded RNA), or exists within a multipro-
tein complex termed the RNA degradosome.10 Although
the cellular function of PNPase obviously differs between
bacteria and mammals, the ability of PNPase monomers
to form trimers is important for both bacteria and
mammals. The deletion of pnp in E. coli is known to cause
a growth deficit under increased oxidative stress induced
by hydrogen peroxide.17 We therefore analyzed bacterial
growth in a pnp-knockout strain (Dpnp, KEIO collection
clone JW5851, National BioResource Project, Japan).
E. coli pnp was cloned into the inducible bacterial ex-
pression vector pBAD-DEST49 (Invitrogen, Darmstadt,
Germany) with the use of plasmid pKAK718 as a template,
and theDpnp strain was transformed with constructs either
expressing E. coli pnp WT (Dpnp/WT) or the analogous
mutant (Dpnp/p.Glu430Gly) (Figure 1F). This was done
because complementation of the bacterial phenotype
with PNPT1, either with or without a MTS, was not effi-
cient (data not shown). Whereas induced expression of
E. coli pnp WT led to a nearly complete rescue of the
H2O2-induced growth defect, expression of the pnpmutant
(Dpnp/p.Glu430Gly) resulted in a significantly diminished
ability to complement the phenotype both in spot tests
and in liquid cultures (Figures 5A and 5B). The growth tests
indicated that the amino acid substitution does not cause
a complete loss of function but rather leads to a strongly
impaired PNPase function, which is consistent with the
finding that a constitutive knockout of murine Pnpt1 is
lethal in the embryonic stage.8Journal of Human Genetics 91, 919–927, November 2, 2012 923
Figure 5. Functional Consequences of
the Identified PNPT1 Mutation
(A–B) Complementation experiments in
bacteria: E. coli pnp-knockout strain
(Dpnp) was transformed with constructs
expressing either bacterial WT or mutant
(p.Glu430Gly) pnp. E. coli K-12 strain
BW25113 was used as a WT reference.
(A) Spot tests. Strains were serially diluted
and grown on lysogeny broth (LB) agar
plates either with or without 0.6 mM
hydrogen peroxide. Growth of Dpnp is
suppressed by hydrogen peroxide and
can be almost completely restored by WT
Pnp but only partially by p.Glu430Gly
Pnp.
(B) Indicated strains were grown in
LB medium and exposed to increasing
concentrations of hydrogen peroxide.
Exogenous expression of WT pnp restores
growth significantly better than does
expression of the pnp mutant encoding
p.Glu430Gly (Student’s two-tailed t test:
*p¼ 7.063 103, **p¼ 2.563 106). Error
bars indicate standard deviation of ten
independent experiments.
(C–D) The assembly state of exogenous
WT and p.Glu475Gly PNPase was deter-
mined by nondenaturing blue-native gel
electrophoresis.
(C) In MEFs with floxed endogenous
mouse Pnpt1 knocked down by CMV-CRE
recombinase-induced partial knockout,
the trimerization of exogenous p.Glu475Gly PNPase is severely impaired and shifted toward monomers.
(D) In the GA74-1A yeast strain, p.Glu475Gly PNPase colocalized with a mitochondrial marker, PORIN, and showed a protein level that
was similar to that of exogenousWT PNPase. However, the assembly of p.Glu475Gly PNPase in a higher-order, trimeric PNPase complex
was impaired compared toWT PNPase, as shown by a significant reduction of the trimer band at ~240 kDa and increase of the monomer
band at ~85 kDa.
(E) RNA import assay in yeast. In-vitro-transcribed human RNase P RNA was incubated with yeast mitochondria expressing WT PNPT1,
a PNPT1 mutant coding for p.Glu475Gly, or an empty vector (‘‘vec’’). Import reactions were repeated with 13 and 23 amounts of
RNA. Abundance of imported RNase P RNA in mitochondria containing p.Glu475Gly PNPase is one quarter of the level of that in
mitochondria containing WT PNPase.
(F) RNA-import assay in MEFs. In-vitro-transcribed human RNase P RNA was incubated with mitochondria isolated from different
MEF lines: WT (mouse Pnpt1 partial knockout plus exogenous WT PNPT1 expression), p.Glu475Gly (Pnpt1 partial knockout plus
exogenous PNPT1 expression encoding p.Glu475Gly), or knockout (Pnpt1 expression reduced by 75%). Import reactions were repeated
with 13 and 23 amounts of RNA. Import of RNase P RNA is two times lower in PNPT1-mutant-expressing mitochondria than in
WT-PNPT1-transduced mitochondria.
(G) Immunoblot of PNPase and mitochondria-localized TOM40 from different MEF lines.The homotrimerization of PNPase is necessary for the
RNA processing and transporting function of the protein,
and the identified missense exchange was predicted to
interfere with oligomerization. We therefore continued
by investigating the ability of p.Glu475Gly PNPase to
assemble into functional trimers by blue-native gel electro-
phoresis, which was performed as previously described.19
When the PNPT1 mutation encoding for PNPase
p.Glu475Gly was exogenously expressed in MEFs with
downregulated endogenous Pnpt1,8 its ability to assemble
into higher-order trimeric PNPase complexes was severely
impaired, as shown by a significant drift of the trimer
band at ~240 kDa to the monomer band at ~85 kDa
(Figure 5C). To a lesser extent, this drift toward monomers
was also seen in yeast cells artificially expressing the
mutated PNPT1 (Figure 5D), thereby confirming the
prediction of the three-dimensional modeling.924 The American Journal of Human Genetics 91, 919–927, NovembFinally, we studied the genuine mammalian function,
mitochondrial RNA import, of WT and p.Glu475Gly
PNPase in yeast and mammalian cells. To analyze mito-
chondrial RNA-import capacity, we isolated mitochondria
from three strains of yeast: WT yeast (which does not have
a PNPT1 ortholog), yeast expressing WT PNPT1, and yeast
expressing the PNPT1 missense mutant coding for
p.Glu475Gly PNPase. This was followed by incubation
with in-vitro-transcribed human RNase P RNA, a known
substrate of PNPase. As expected, the amount of RNase
P RNA import was much higher in mitochondria ex-
pressing WT PNPT1 than in yeast mitochondria con-
taining an empty vector.8 In contrast, mitochondria
expressing the PNPT1 missense mutant construct coding
for p.Glu475Gly PNPase showed two times more RNase
P RNA than did empty-vector-containing yeast mitochon-
dria but showed 75% less RNA than did mitochondriaer 2, 2012
expressing WT PNPT1 (Figure 5E), suggesting that in yeast
cells p.Glu475Gly PNPase is only partially functional for
RNA import. Furthermore, to providemammalian cell rele-
vance, we also expressed WT or mutant PNPT1 in MEFs
with floxed endogenous mouse Pnpt1 knocked down by
CMV-CRE recombinase-induced partial knockout. The
level of p.Glu475Gly PNPase in MEF mitochondria was
similar to exogenous protein levels of WT PNPase
(Figure 5G). PNPT1-mutant-transduced mitochondria
showed two times less RNase P RNA import than did exog-
enous WT-PNPT1-expressing mitochondria (Figure 5F).
Compared with the RNase P RNA import in the yeast
assay, the less-pronounced reduction in RNase P RNA
import in MEFs is probably related to the amount of
endogenous WT PNPase that is required for maintaining
cell viability in the MEFs. The import of RNase P RNA
into p.Glu475Gly-PNPase-containing mitochondria, how-
ever, was slightly higher than that into MEF mitochondria
containing ~33% of the endogenous level of PNPase,
consistent with a role for p.Glu475Gly PNPase as a hypo-
morph in mammalian cells. Both the yeast and the
mammalian RNA-import assays were performed as previ-
ously described.8 All together, our functional analyses
in bacteria, yeast, and mammalian cells show a severe
functional PNPase impairment caused by the identified
PNPT1 missense mutation.
The inner ear is one of the tissues with a relatively high
energy demand, which is supported by the finding that
selected mtDNA mutations—such as the m.1555A>G
mutation in the mitochondrial 12S rRNA gene (MIM
500008) or mutations in the tRNASer gene (MIM
590080)—cause nonsyndromic hearing impairment.20
Other mtDNA mutations are found in syndromic types
of hearing impairment often characterized by additional
neurologic, cardiologic, or metabolic symptoms.20 In
many cases, mtDNA mutations do not cause an overt
hearing phenotype at all, demonstrating the variable
expressivity and incomplete penetrance of diseases arising
from mtDNA mutations.21 In addition, mutations in
nuclear genes encoding for proteins necessary for mito-
chondrial function can cause secondary types of mito-
chondrial diseases.22 This group of disorders could, in
principle, manifest as syndromic or nonsyndromic types
of hearing impairment, but most of them do not show
a prominent hearing involvement or, even less, an exclu-
sive disturbance of the inner ear. Indeed, and despite the
extreme locus heterogeneity of autosomal-recessive non-
syndromic hearing impairment (see Hereditary Hearing
Loss Homepage and Dror and Avraham23), just recently
the first mutations in a nuclear gene (MSRB3) encoding
a protein with a possible mitochondrial function have
been described in ARNSHI (MIM 613718).24 MSRB3
encodes the zinc-containing methionine sulfoxide re-
ductase B3, which has been reported to have human
isoforms with MTSs, although the mouse ortholog does
not have a functional MTS and is exclusively localized in
the endoplasmic reticulum.25 Whether or not this formThe Americanof ARNSHI is indeed mitochondrial in origin, it is evident
that nonsyndromic types of hearing impairment are rarely
caused by mutations in nuclear genes encoding proteins
with a mitochondrial function, indicating that most mito-
chondrial processes and functions are not specifically
important for the function of the inner ear. In this report,
we add autosomal-recessive, congenital, nonsyndromic
hearing impairment type DFNB70 to the growing list of
secondary mitochondrial diseases, and it belongs to the
rare group of early-onset but seeminglymonosymptomatic
mitochondrial disorders. Although we cannot exclude the
future development of additional late-onset symptoms in
affected family members, the disease in all three affected
individuals is clearly dominated by a congenital and
profound hearing impairment, and, until now, there
have been no obvious additional symptoms present in
any of these individuals.
On the basis of three-dimentional-modeling data, the
identified p.Glu475Gly alteration is predicted to cause
a disturbance of the quaternary structure of the PNPase
trimer, which we verified experimentally in yeast and
mammalian cells. This kind of structural trimerization
disturbance, which impairs PNPase function, was shown
before for the artificial protein variant p.Asp135Gly.26
Also, we demonstrated that impaired trimerization
causes a severely reduced functionality of PNPase in cells
of such diverse species as E. coli, S. cerevisiae, and
M. musculus. Interestingly, the functional studies con-
sistently showed that p.Glu475Gly PNPase behaves as
a hypomorph, which is consistent with expectations given
that a constitutive knockout of the murine gene is not
compatible with life.8 Together with the genetic data and
our detection of evolutionarily conserved Pnpt1 and
pnpt1 expression in the ear, the functional studies have
thus confirmed the pathogenic role of the identified
missense mutation and the identification of PNPT1 as
a gene whose dysfunction can cause autosomal-recessive
hearing loss. If one were to think about other types of
potential PNPT1 mutations, it seems possible that
mutations causing an even more pronounced loss of
function without being a null allele—which could well
be lethal, like in the mouse—might manifest as a syn-
dromic type of deafness with involvement of additional
organ systems of high energy demand. On the other
hand, PNPT1mutations causing a functional deficit milder
than that observed for p.Glu475Gly might, as a result of
the importance of PNPase function in the inner ear,
show a progressive late-onset type of hearing loss or an
increased susceptibility toward complex inherited
presbyacusis, which is speculated to have at least in part
a mitochondrial origin.27
In summary, we elucidated a hereditary disturbance
of mitochondrial RNA import by the identification of a
hypofunctional mutation in PNPT1 in congenital severe
hearing impairment, demonstrating the rather unex-
pected and specific importance of PNPase for auditory
function.Journal of Human Genetics 91, 919–927, November 2, 2012 925
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